Osaic Holdings
PCRX icon

Osaic Holdings’s Pacira BioSciences PCRX Stock Holding History

Osaic Holdings’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$421K Sell
16,588
-390
-2% -$9.22K ﹤0.01% 3805
2026
Q1 		$384K Buy
16,978
+5,058
+42% +$112K ﹤0.01% 3608
2025
Q4 		$308K Buy
11,920
+9,652
+426% +$230K ﹤0.01% 3786
2025
Q3 		$60.3K Sell
2,268
-45
-2% -$1.1K ﹤0.01% 5191
2025
Q2 		$55.3K Buy
2,313
+49
+2% +$1.24K ﹤0.01% 4976
2025
Q1 		$56.3K Buy
2,264
+1,117
+97% +$26.7K ﹤0.01% 4627
2024
Q4 		$21.6K Buy
1,147
+407
+55% +$7.15K ﹤0.01% 5287
2024
Q3 		$11.1K Sell
740
-926
-56% -$15.8K ﹤0.01% 5759
2024
Q2 		$47.7K Sell
1,666
-1,080
-39% -$30.7K ﹤0.01% 4716
2024
Q1 		$80.2K Sell
2,746
-2,536
-48% -$77.9K ﹤0.01% 4399
2023
Q4 		$178K Sell
5,282
-676
-11% -$19.8K ﹤0.01% 4021
2023
Q3 		$183K Buy
5,958
+482
+9% +$17.4K ﹤0.01% 4060
2023
Q2 		$219K Sell
5,476
-524
-9% -$21.7K ﹤0.01% 3822
2023
Q1 		$245K Sell
6,000
-9,636
-62% -$383K ﹤0.01% 3710
2022
Q4 		$604K Sell
15,636
-719
-4% -$35K ﹤0.01% 2858
2022
Q3 		$868K Buy
16,355
+550
+3% +$30.6K ﹤0.01% 2366
2022
Q2 		$922K Sell
15,805
-7,310
-32% -$479K ﹤0.01% 2359
2022
Q1 		$1.76M Buy
23,115
+6,625
+40% +$442K ﹤0.01% 2032
2021
Q4 		$993K Buy
16,490
+10,191
+162% +$562K ﹤0.01% 2413
2021
Q3 		$353K Buy
6,299
+509
+9% +$29.3K ﹤0.01% 3383
2021
Q2 		$354K Sell
5,790
-50
-0.9% -$3.17K ﹤0.01% 3361
2021
Q1 		$410K Sell
5,840
-144
-2% -$10.3K ﹤0.01% 3088
2020
Q4 		$359K Sell
5,984
-122
-2% -$7.14K ﹤0.01% 2948
2020
Q3 		$367K Buy
6,106
+1,590
+35% +$92.4K ﹤0.01% 2712
2020
Q2 		$234K Buy
4,516
+509
+13% +$21.3K ﹤0.01% 2986
2020
Q1 		$135K Buy
+4,007
New +$166K ﹤0.01% 3229

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's PCRX Position: Q2 2026 in Review

Osaic Holdings reduced its Pacira BioSciences (PCRX) stake by 2.3% in Q2 2026, selling an estimated $9.22K and leaving 16,588 shares worth $421K. The position accounts for ﹤0.01% of the portfolio, ranked #3805.

Osaic Holdings first reported a position in PCRX in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.76M in Q1 2022. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Osaic Holdings held 16,588 shares of Pacira BioSciences worth $421K as of Q2 2026.
  • Osaic Holdings sold 390 Pacira BioSciences shares in Q2 2026, an estimated $9.22K.
  • Pacira BioSciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3805 holding.
  • Osaic Holdings first reported a position in Pacira BioSciences in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Pacira BioSciences position peaked at $1.76M in Q1 2022.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.